Anti-Cancer Drugs

Article	Citations
Effect of berbamine on invasion and metastasis of human liver cancer SMMC-7721 cells and its possible mechanism	55
FV-429 suppresses cancer cell migration and invasion by EMT via the Hippo/YAP1 pathway in pancreatic cancer cells	51
eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma	24
Hypoxia-inducible factor-1α inhibition augments efficacy of programmed cell death 1 antibody in murine prostatic cancer models	21
BTK inhibitors enhance NKG2D ligand expression by regulating IL-10/STAT3 pathway in activated non-GCB diffuse large B-cell lymphoma cells	20
Rapid and durable response to fifth-line lorlatinib plus olaparib in an ALK-rearranged, BRCA2-mutated metastatic lung adenocarcinoma patient with critical tracheal stenosis: a case report	19
A retrospective assessment of real-world experience with venetoclax and azacitidine therapy in elderly acute myeloid leukemia	19
YKL-06-061 exerts antitumor effect through G1/S phase arrest by downregulating c-Myc and inhibition of metastasis via SIK1 upregulation in pancreatic cancer	18
Pyrotinib treatment enhances the radiosensitivity in HER2-positive brain metastatic breast cancer patients	18
Circ_0003998 upregulates ARK5 expression to elevate 5-Fluorouracil resistance in hepatocellular carcinoma through binding to miR-513a-5p	18
Neutrophil-to-lymphocyte ratio predicts therapy outcomes of transarterial chemoembolization combined with tyrosine kinase inhibitors plus programmed cell death ligand 1 antibody for unresectable hepat	18
Knockdown of circLRWD1 weakens DDP resistance via reduction of SIRT5 expression through releasing miR-507 in non-small cell lung cancer	18
Acquired EML4-ALK fusion and EGFR C797S in cis mutation as resistance mechanisms to osimertinib in a non-small cell lung cancer patient with EGFR L858R/T790M	17
Circular RNA circ_0073181 contributes to tumorigenesis by regulating protein tyrosine phosphatase receptor type E via miR-548p in hepatocellular carcinoma	16
Nivolumab combined docetaxel versus nivolumab in patients with previously treated nonsmall cell lung cancer: a phase 2 study	16
WISP1 inhibition of YAP phosphorylation drives breast cancer growth and chemoresistance via TEAD4 activation	16
Long noncoding RNA ZFPM2-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by regulating the miR-576-3p/HIF-1α axis	15
Interferon-α1b for the treatment of metastatic melanoma: results of a retrospective study	15
Partial response of metastatic cardia neuroendocrine carcinoma with the combined therapy involving PD-1 blockade after failed multi-line chemotherapies: a case report and literature review	14
CircRNA B cell linker regulates cisplatin sensitivity in nonsmall cell lung cancer via microRNA-25-3p/BarH‑like homeobox 2 axis	14
Complete response of recurrent perihilar cholangiocarcinoma following sintilimab combined with lenvatinib plus S-1: a case report and review of literature	14
Aumolertinib-based comprehensive treatment for an uncommon site of EGFR exon 20 insertion mutations with multiple metastases non-small cell lung cancer: a case report	14
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients	13
LncRNA FOXP4-AS1 silencing inhibits metastasis and epithelial–mesenchymal transition in nasopharyngeal carcinoma via miR-136-5p/MAPK1	13
Computational study of novel natural inhibitors targeting Kirsten rat sarcoma viral oncogene homolog G12C	13

Interference with PLA2G16 promotes cell cycle arrest and apoptosis and inhibits the reprogramming of glucose metabolism in multiple myeloma cells by modulating the Hippo/YAP signaling pathway	13
Downregulation of RPS14 inhibits the proliferation and metastasis of estrogen receptor-positive breast cancer cells	13
Circ_0005615 contributes to the progression and Bortezomib resistance of multiple myeloma by sponging miR-185-5p and upregulating IRF4	13
Transcription factor ZEB1 regulates PLK1-mediated SKA3 phosphorylation to promote lung cancer cell proliferation, migration and cell cycle	12
Anoikis-related lncRNA signature predicts prognosis and is associated with immune infiltration in hepatocellular carcinoma	12
Repurposing calcium channel blockers: may be sensible combination with erlotinib for non-small cell lung cancer	12
Remarkable response to gemcitabine rechallenge in advanced urothelial carcinoma: a case report	12
APLNR promotes the progression of osteosarcoma by stimulating cell proliferation and invasion: Retraction	11
Real-world efficacy and safety of lorlatinib in treating advanced ALK-positive non–small cell lung cancer patients	11
Venetoclax-induced vitiligo in a patient with chronic lymphocytic leukemia	11
Bevacizumab and anexelekto inhibitor, TP-0903 inhibits TGF-β1-induced epithelial–mesenchymal transition of colon cancer cells	11
HER2-positive advanced biliary tract cancer responds to second-line pyrotinib therapy: a case report	11
Identification of exosomal circRNA CD226 as a potent driver of nonsmall cell lung cancer through miR-1224-3p/high mobility group AT-hook 2 axis	11
M2 tumor-associated macrophage promoted DNA methylation in lung cancer metastasis via intensifying EZH2	11
TRIM11 expression levels was downregulated and prevents ferroptosis of cardiomyocyte by Dusp6 in acute myocardial infarction	11
Circular RNA circ_0000592 elevates ANXA4 expression via sponging miR-1179 to facilitate tumor progression in gastric cancer	11
Afatinib in the treatment of brain metastases of lung cancer with one rare EGFR mutation: a two-case report	11
Real-life data on adjuvant trastuzumab emtansine treatment in early-stage HER2-positive breast cancer: a Turkish Oncology Group study	10
ZNF668: a new diagnostic predictor of kidney renal clear cell carcinoma	10
Epidermal growth factor receptor mutation p.A864V in small cell lung cancer and lung squamous cell carcinoma: a case report and review of literature	10
Electrochemotherapy with bleomycin as an effective local treatment for Kaposi’s sarcoma: a case report	10
Osimertinib is an effective epidermal growth factor receptor-tyrosine kinase inhibitor choice for lung cancer with epidermal growth factor receptor exon 18–25 kinase domain duplication: report of two	10
Pazopanib-induced chylothorax in a patient with renal cell carcinoma	10
Anticancer properties of novel zinc oxide quantum dot nanoparticles against breast cancer stem-like cells	10
Anlotinib is effective in the treatment of advanced pancreatic cancer: a case report	10
Impact of KMN network genes on progression and prognosis of non-small cell lung cancer	10
Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells	9
Successful treatment with lenvatinib in a patient with thymic carcinoma presenting with cardiac tamponade: a case report and review of literature	9
CircSETDB1 contributes to paclitaxel resistance of ovarian cancer cells by sponging miR-508-3p and regulating ABCC1 expression	9
DNA methyltransferase inhibitor 5-azacytidine enhances neuroblastoma cell lysis by an oncolytic parainfluenza virus	9
miR-26b-5p suppresses chemoresistance in breast cancer by targeting serglycin	9
Tislelizumab plus chemotherapy is an optimal option for second-line treatment for advanced gastroesophageal junction adenocarcinoma	9
HMOX1 regulates ferroptosis via mic14 and its impact on chemotherapy resistance in small-cell lung cancer	9
Differential functionality of fluoropyrimidine nucleosides for safe cancer therapy	9
MiR-30a-5p/CHD1 axis enhances cisplatin sensitivity of ovarian cancer cells via inactivating the Wnt/β-catenin pathway	9
Successful immunotherapy with PD-1 Iinhibitor for advanced pancreatic cancer: report of two cases and review of literature	9
Extended survival in a case of metastatic choroidal melanoma with immunotherapy	9
Identifying predictive biomarkers of apatinib in third-line treatment of advanced colorectal cancer through comprehensive genomic profiling	9
Circ_0009035 regulates the progression of cervical cancer by targeting miR-1305/CREBRF axis	9
Evaluation of nuclear PGAM2 value in hepatocellular carcinoma prognosis	9
Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient	8
Circ_0001658 regulates gefitinib resistance of non-small cell lung cancer through miR-409-3p/TWIST1 axis	8
Intravenous immunoglobulin efficacy on pembrolizumab induced severe toxic epidermal necrolysis	8
Reuse of osimertinib after small cell lung cancer transformation in lung adenocarcinoma with de-novo epidermal growth factor receptor T790M mutation: case report	8
Apoptotic and autophagic cell death induced in cervical cancer cells by a dual specific oncolytic adenovirus	8
Ado-trastuzumab emtansine in the treatment of lung adenocarcinoma with ERBB2 mutation: a case report and literature review	8
Biodegradable controlled-release polymer containing butylidenephthalide to treat a recurrent cervical spine glioblastoma with promising result: a compassionate trial report	8
Analysis of clinical factors associated with survival in patients with soft-tissue sarcoma receiving trabectedin	8
Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression	8
Kruppel-like factor 5 enhances proliferation, lipid droplet formation and oxaliplatin resistance in colorectal cancer by promoting fatty acid binding protein 6 transcription	8

Complete response to first-line osimertinib monotherapy in a complex epidermal growth factor receptor mutant (L833V/H835L) lung adenocarcinoma patient: a case report	8
Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma	8
Berberine inhibits prostate cancer progression by inducing ferroptosis: evidence from network pharmacology	8
Salvage chemotherapy in patients with nonsmall cell lung cancer after prior immunotherapy: a retrospective, real-life experience study	8
Effect of statins use on risk and prognosis of breast cancer: a meta-analysis	8
Circ_0085495 knockdown reduces adriamycin resistance in breast cancer through miR-873-5p/integrin β1 axis	8
AZD7762 induces CRBN dependent BAG3 degradation through ubiquitin-proteasome pathway	8
Immunotherapy combined with chemotherapy in the treatment for rare primary mucoepidermoid carcinoma of the liver: a case report	8
What management for epidermal growth factor receptor-mutated non–small-cell lung cancer, with squamous cell transformation and T790M-acquired resistance mechanisms? A Case report and review of literat	7
CDKN2A inhibited ferroptosis through activating JAK2/STAT3 pathway to modulate cisplatin resistance in cervical squamous cell carcinoma	7
Mucinous appendiceal adenocarcinoma invading the bladder: not always an easy diagnosis. A case report	7
Lidocaine hampers colorectal cancer process via circITFG2/miR-1204/SOCS2 axis	7
Clinical and radiological evaluation of a phyllodes tumor of the breast: a case report	7
GATA3 positively regulates PAR1 to facilitate in vitro disease progression and decrease cisplatin sensitivity in neuroblastoma via inhibiting the hippo pathway	7
Potential mechanism of pyrotinib-induced diarrhea was explored by gut microbiome and ileum metabolomics	7
Hemodialysis requirement after the first dose of durvalumab following chemoradiation therapy: a case report	7
Pyrotinib for HER2-amplified non-small cell lung cancer patient after progression to Afatinib: a case report	7
Long-term survival of an ALK fusion lung adenocarcinoma patient with high mutation burden and microsatellite instability high: a case report	7
M2 macrophage-derived exosomal miR-1911-5p promotes cell migration and invasion in lung adenocarcinoma by down-regulating CELF2-activated ZBTB4 expression	7
A late relapse thymoma and pure red cell aplasia case with an over 5 years of clinical response under everolimus	7
Diagnostic and prognostic value of serum soluble B7-H3 in nonsmall cell lung cancer	7
MiR-302c-5p affects the stemness and cisplatin resistance of nasopharyngeal carcinoma cells by regulating HSP90AA1	6
Efficacy and safety of sintilimab combined with apatinib as third-line or above therapy for patients with advanced or metastatic gastric cancer	6
Immunotherapy rechallenge of advanced lung adenocarcinoma with cadonilimab (PD-1/CTLA-4 Bi-specific antibody): a case report	6
Utidelone plus pembrolizumab as the fourth-line combination treatment in non-small cell lung cancer with EGFR mutation: a case report	6
GZ17-6.02 interacts with carboplatin and etoposide to kill neuroblastoma cells	6
DEPDC1 affects autophagy-dependent glycolysis levels in human osteosarcoma cells by modulating RAS/ERK signaling through TTK	6
Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy	6
Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis	6
Pretreatment platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as a predictor of pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: single center	6
Stewart-Treves syndrome in an older woman successfully treated by metronomic chemotherapy: case report and literature survey	6
Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model	6
Pulmonary toxicity following administration of granulocyte colony-stimulating factor during chemotherapy for breast cancer: a case report and literature review	6
CircFOXM1 silencing represses cell proliferation, migration and invasion by regulating miR-515-5p/ADAM10 axis in prostate cancer	6
Exosomal miR-93-5p from cancer-associated fibroblasts confers malignant phenotypes on bladder cancer cells by targeting PAFAH1B1	6
Mechanism of gemcitabine combined with lobaplatin in interventional treatment of locally advanced cervical cancer	6
First case report of sunvozertinib for the treatment of HER2 exon 20 insertion in lung adenocarcinoma	6
Antineoplastic activity of GP-2250 in-vitro and in mouse xenograft models	6
Combating anoikis resistance: bioactive compounds transforming prostate cancer therapy	6
Exosomal circ_0007385 enhances non-small cell lung cancer cell proliferation and stemness via regulating miR-1253/FAM83A axis	6
Response to olaparib in metastatic lung adenocarcinoma with germline BRCA2 mutation: a case report	6
Circ_0027089 regulates NACC1 by targeting miR-136-5p to aggravate the development of hepatitis B virus-related hepatocellular carcinoma	6
A meta-analysis of the effect and safety of platinum-based neoadjuvant chemotherapy in treatment of resectable triple-negative breast cancer	6
Concurrent NRAS-BRAF variants in metastatic colorectal cancer: a Tunisian case report	6
Norcantharidin counteracts acquired everolimus resistance in renal cell carcinoma by dual inhibition of mammalian target of rapamycin complex 1 and complex 2 pathways in Vitro	6
Azacitidine combined with venetoclax alleviates AML-MR with TP53 mutation in SDS: a case report and literature review	6
Hyper-late major response after 5 years of nivolumab: role of treatment beyond progression in head and neck cancer	6
Comparison of effects of tamoxifen and Toremifene on hepatic function and serum lipids in breast cancer patients during adjuvant endocrine therapy	6
A meta-analysis on overall survival and safety outcomes in patients with nonmetastatic castration-resistant prostate cancer treated with novel hormonal agents	6
A dual thermo/pH-sensitive hydrogel as 5-Fluorouracil carrier for breast cancer treatment	6
Exploring the repurposing potential of telmisartan drug in breast cancer: an in-silico and in-vitro approach	6
A case of lung adenocarcinoma with MET∆ex14 mutation regressed after preoperative treatment with savolitinib, and successfully underwent radical resection	5
Response to erlotinib and bevacizumab combination therapy after acquired resistance to osimertinib in patients with non-small cell lung cancer	5
Chemoimmunotherapy after progression on single-agent pembrolizumab for metastatic urothelial carcinoma: a case series	5
Long-term extracranial metastatic relapse of an intraventricular solitary fibrous tumor: a case report	5
Combined protein and transcriptomics identifies DCTPP1 as a putative biomarkers for predicting immunotherapy responsiveness in gastric cancer patients	5
Anti-androgen for myoepithelial tumor: a potent therapy yet a potential misleader	5
LMCD1 antisense RNA 1 is a newly identified long noncoding RNA	5
Knockdown of circ-PIP5K1A overcomes resistance to cisplatin in ovarian cancer by miR-942-5p/NFIB axis	5
Successful treatment of severe lung cancer caused by third-generation EGFR-TKI resistance due to EGFR genotype conversion with afatinib plus anlotinib	5
First-line crizotinib therapy is effective for a novel SEC31A-anaplastic lymphoma kinase fusion in a patient with stage IV lung adenocarcinoma: a case report and literature reviews	5
LncRNA PCAT6 activated by SP1 facilitates the progression of breast cancer by the miR-326/LRRC8E axis	5
Stat3 shRNA delivery with folate receptor-modified multi-functionalized graphene oxide particles for combined infrared radiation and gene therapy in hepatocellular carcinoma	5
Therapeutic effects of vitamin D and IL-22 on methotrexate-induced mucositis in mice	5
Pathological complete response achieved with FLOT chemotherapy in two patients with MSI-H esophagogastric junction and gastric adenocarcinoma	5
USP3 promotes cisplatin resistance in non-small cell lung cancer cells by suppressing ACOT7-regulated ferroptosis	5
A review of research progress on mechanisms and overcoming strategies of acquired osimertinib resistance	5
The prognostic values of prognostic nutritional index in extensive-stage small-cell lung cancer	5
Propranolol suppresses infantile hemangioma cell proliferation and promotes apoptosis by upregulating miR-125b expression: Retraction	5
Effect of GADD45G on the radioresistance of nasopharyngeal carcinoma cells	5
Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis	5
Association between SLCO1B1 polymorphism and methotrexate-induced hepatotoxicity: a systematic review and meta-analysis	5
Risk-tailored treatment of splenic marginal zone lymphoma	5
Asynchrony of primary tumor and mediastinal lymph nodes response after neoadjuvant immunotherapy plus chemotherapy in a patient with stage IIIA non–small-cell lung cancer: a case report	5
Metastatic small cell lung cancer – an aggressive disease: a case report and literature review	5
Methyltransferase-like 3 enhances cell proliferation and cisplatin resistance in natural killer/T-cell lymphoma through promoting N6-methyladenosine modification and the stability of staphylococcal nu	5
In regard to Cabezas-Camarero et al.	5
Unexpected response to fourth-line paclitaxel in a patient with metastatic oropharyngeal squamous cell carcinoma, immunotherapy-refractory: a case report	5
Long-term response to immuno-oncology after discontinuation for immuno-related pneumonia in metastatic renal carcinoma: a case report	5
BAP1 loss confers sensitivity to bromodomain and extra-terminal inhibitors in renal cell carcinoma	5

Inhibition of MNK pathway sensitizes nasopharyngeal carcinoma to radiotherapy	5
The role of emodin on cisplatin resistance reversal of lung adenocarcinoma A549/DDP cell	5
Research on the mechanism of eugenol in the treatment of liver cancer based on network pharmacology, molecular docking technology, and in vitro experiments	5
Natural products inducing nucleolar stress: implications in cancer therapy	5
Advanced ovarian clear cell carcinoma with RAD50 mutation treated by PARP inhibitor pamiparib combined with anti-angiogenesis therapy: a case report	4
KAT8 enhances the resistance of lung cancer cells to cisplatin by acetylation of PKM2	4
MicroRNA-301b and its target gene synaptosome-associated protein 91 as important modulators in esophageal cancer: functional experiments: Retraction	4
LncRNA PROX1 antisense RNA 1 promotes PD-L1-mediated proliferation, metastasis, and immune escape in colorectal cancer by interacting with miR-520d	4
M6A methylation of FKFB3 reduced pyroptosis of gastric cancer by NLRP3	4
Neoadjuvant alectinib in locally advanced lung adenocarcinoma with anaplastic lymphoma kinase rearrangement: case series and literature review	4
Transformation of lung adenocarcinoma to small cell lung cancer following osimertinib treatment: a case report and literature review	4
Key considerations when using the sulforhodamine B assay for screening novel anticancer agents	4
circUBAP2 inhibits cisplatin resistance in gastric cancer via miR-300/KAT6B axis	4
Circ_0039569 contributes to the paclitaxel resistance of endometrial cancer via targeting miR-1271-5p/PHF6 pathway	4
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601	4
Design of potential anti-cancer agents as COX-2 inhibitors, using 3D-QSAR modeling, molecular docking, oral bioavailability proprieties, and molecular dynamics simulation: Erratum	4
Perforated appendicitis induced by pembrolizumab: a case report and review of the literature	4
miR-143-3p represses leukemia cell proliferation by inhibiting KAT6A expression	4
Stereotactic body radiotherapy and poly (ADP-ribose) polymerase inhibitors in ovarian cancer: a knowledge and attitudes survey in collaboration with the Italian Association of Radiation Oncology (AIRO	4
Efficacy and safety of toripalimab combined with doxorubicin as first-line treatment for metastatic soft tissue sarcomas: an observational study	4
Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network	4
Preliminary results of randomized phase II study of etoposide plus lobaplatin or etoposide plus cisplatin with concurrent thoracic radiotherapy in the treatment of limited-stage small cell lung cancer	4
Immune checkpoint inhibitors for RET fusion non-small cell lung cancer: hopes and challenges	4
Twelve-month progression-free survival with sotorasib and panitumumab in KRAS G12C mutant metastatic colorectal cancer	4
LncRNA MSC-AS1, as an oncogene in melanoma, promotes the proliferation and glutaminolysis by regulating the miR-330-3p/YAP1 axis	4
aYAP1-2 contributes to bFGF-induced proliferation In gastric cancer	4
Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer	4
Design of novel quinoline derivatives as antibreast cancer using 3D-QSAR, molecular docking and pharmacokinetic investigation	4
Primary pleural epithelioid hemangioendothelioma: case report and review of the literature	4
Hypophysitis secondary to pembrolizumab: a case report and review of the literature	4
Does bevacizumab carry a hope for metastatic triple-negative breast cancer in the era of immunotherapy?	4
Sustained antitumor response to lenvatinib with weekend-off and alternate-day administration in chemotherapy-refractory thymic carcinoma: a case report	4
Immune-checkpoint inhibitors in pituitary malignancies	4
Occult epidermal growth factor receptor-mutant lung adenocarcinoma complicated by prostatic metastasis: a case report	4
The efficacy and safety of adding anlotinib in gradual progression on third-generation EGFR-TKIs for EGFR-mutant advanced nonsmall cell lung cancer	4
Dinaciclib exerts a tumor-suppressing effect via β-catenin/YAP axis in pancreatic ductal adenocarcinoma	4
Daratumumab-lenalidomide and daratumumab-pomalidomide in relapsed lenalidomide-exposed or refractory multiple myeloma	4
A chance in hopeless cancer: 5-year complete remission after oxaliplatin-based therapy in a patient with BRCA2 mutant metastatic pancreatic cancer	4
Unexpected favorable outcome to sintilimab monotherapy in a relapse pancreatic ductal adenocarcinoma patient with high tumor mutational burden: a case report	4
Jackfruit waste: an invented anticancer therapy using Jacalin lectin from jackfruit seed	4
LncRNA SNHG11 enhances bevacizumab resistance in colorectal cancer by mediating miR-1207-5p/ABCC1 axis	4
A novel intergenic region ALK fusion is targetable by alectinib in a non-small cell lung cancer patient with brain metastasis	4
Combination of anlotinib and sintilimab for the treatment of recurrent or metastatic head and neck squamous cell carcinoma: a single-arm prospective study	4
Efficacy of disitamab vedotin (RC48) for previously treated human epidermal growth factor receptor 2–positive breast cancer with symptomatic brain metastases: a case report and review of the literatur	4
Anlotinib in patients with relapsed or refractory thymic epithelial tumors: a study of 50 cases	4
Circ_0058063 promotes progression of thyroid cancer by sponging miR-330-3p/SDC4 axis	4
Dramatic response to crizotinib in a breast cancer patient with ALK gene rearrangement	4
Efficacy and safety of anlotinib as maintenance therapy after induction chemotherapy in extensive-stage small-cell lung cancer	4
LncRNA LINC01871 sponging miR-142-3p to modulate ZYG11B promotes the chemoresistance of colorectal cancer cells by inducing autophagy	4
A case report of a lung cancer patient with two uncommon EGFR mutations and a review of the literature: two sides of the same coin	4
RIDR-PI-103, ROS-activated prodrug PI3K inhibitor inhibits cell growth and impairs the PI3K/Akt pathway in BRAF and MEK inhibitor-resistant BRAF-mutant melanoma cells	4
Hypotension from afatinib in epidermal growth factor receptor-mutated non-small cell lung cancer: a case report and literature review	4
Poor response to selpercatinib plus crizotinib in a rearranged during transfection fusion-positive patient with acquired selpercatinib-resistant MNNG HOS transforming amplification: a case report	4
STK25: a viable therapeutic target for cancer treatments?	4
Circular RNA circ_0000212 accelerates cervical cancer progression by acting as a miR-625-5p sponge to upregulate PTP4A1	3
CircPIM3 regulates taxol resistance in non-small cell lung cancer via miR-338-3p/TNFAIP8 axis	3
Complete pathological response with diabetic ketoacidosis to the combination of sintilimab and anlotinib in an unresectable hepatocellular carcinoma patient: a case report	3
Long noncoding RNA ALOX12-AS1 inhibits cervical cancer cells proliferation via targeting miR-3171	3
Dual targeting of Mcl-1 and Bcl-2 to overcome chemoresistance in cervical and colon cancer	3
Enhanced cytotoxic activity of beta carotene conjugated liposomes towards breast cancer cell line: comparative studies with cyclophosphamide	3
MYBPC1 is a key regulator for laryngeal carcinoma formation	3
Clinicopathological significance and prognostic value of P27 expression in gastric cancer patients: a meta-analysis	3
Anlotinib treatment in elderly patients with unresectable or metastatic soft tissue sarcoma: a retrospective study	3
A comprehensive clinical evaluation of HER2-TKIs in patients with previously treated HER2-positive metastatic breast cancer	3
Complete response in patient with liver metastasis of HER2-positive breast cancer following therapy with margetuximab: a case report	3
Inhibiting FGFR by toadflax reverses erlotinib resistance in nonsmall cell lung cancer	3
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer	3
Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis	3
Circular RNA circ_0007841 participates in progression of nonsmall cell lung cancer via miR-199a-5p/SphK2 axis	3
Transcriptome and metabolome sequencing identifies glutamate and LPAR1 as potential factors of anlotinib resistance in thyroid cancer	3
EGFR exon 18 delE709_T710insD mutated stage IV non-small cell lung cancer treated with osimertinib: a case report	3
Urinary exosomal mRNA as a biomarker for the diagnosis of bladder cancer	3
NFATc2 promotes lactate and M2 macrophage polarization through USP17 in lung adenocarcinoma	3
Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors	3
Circular RNA sterile alpha motif domain containing 4A contributes to cell 5-fluorouracil resistance in colorectal cancer by regulating the miR-545-3p/6-phosphofructo-2-kinase/fructose-2,6-bisphosphata	3
Fifty-five months progression-free survival with crizotinib treatment in coexistence of ALK and ROS1 rearrangements in lung adenocarcinoma: an extremely rare case and review of the literature	3
MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression	3
Circular RNA circVPRBP serves as a microRNA-106b-5p sponge to regulate proliferation and metastasis of cervical cancer cells via tripartite motif-containing protein 3	3
Selective synergistic anticancer effects of cisplatin and oridonin against human p53-mutant esophageal squamous carcinoma cells	3
Experience with pembrolizumab in a renal transplant patient with advanced lung cancer: a case report and review	3
Neoadjuvant target therapy with ensartinib in lung adenocarcinoma with EML4-ALK fusion variant: a case report and literature review	3
Prophylactic role of pentoxifylline against paclitaxel-induced neuropathy among patients with breast cancer: a randomized-controlled trial	3
Lung metastases after liver cancer resection cured by immunotherapy: case report and literature review	3
Bergaptol inhibits glioma cell proliferation and induces apoptosis via STAT3/Bcl-2 pathway	3
FSP1 expression as a predictor of platinum resistance and recurrence in epithelial ovarian cancer	3
Furmonertinib and intrathecal pemetrexed chemotherapy rechallenges osimertinib-refractory leptomeningeal metastasis in a non-small cell lung cancer patient harboring EGFR20 R776S, C797S, and EGFR21 L8	3
Savolitinib monotherapy exerted significant benefit in a non-small cell lung cancer patient with osimertinib resistance harboring primary EGFR L858R mutation and MET amplification: a case report	3
Successful treatment of refractory retroperitoneal Epstein-Barr virus-positive diffuse large B-cell lymphoma with secondary hemophagocytic syndrome by sequential combination regimen of PD-1 blockade a	3
Myricetin is effective and selective in inhibiting imatinib-resistant chronic myeloid leukemia stem and differentiated cells through targeting eIF4E	3
MicroRNA-148a/152 cluster restrains tumor stem cell phenotype of colon cancer via modulating CCT6A	3
Ubiquitin-specific protease 1 inhibition sensitizes hepatocellular carcinoma cells to doxorubicin by ubiquitinated proliferating cell nuclear antigen–mediated attenuation of stemness	3
The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors	3
High grade neuroendocrine carcinoma of the breast, first line and maintenance immunotherapy	3
Hsa_circ_0000877 facilitates the progression of diffuse large B-cell lymphoma by miR-370-3p/mitogen-activated protein kinase kinase kinase kinase 4/Hippo pathway	3
STK214947, a novel indole alkaloids, inhibits HeLa and SK-HEP-1 cells survival and EMT process by bloking the Notch3 and Akt signals	3